Development of an AIDS vaccine: a daunting epidemiological challenge

Eur J Epidemiol. 2005;20(2):123-6. doi: 10.1007/s10654-004-6919-3.
No abstract available

Publication types

  • Comparative Study
  • Editorial

MeSH terms

  • AIDS Vaccines* / immunology
  • AIDS Vaccines* / therapeutic use
  • Acquired Immunodeficiency Syndrome / etiology
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Acquired Immunodeficiency Syndrome / virology
  • Animals
  • Antibodies, Viral / analysis
  • Clinical Trials as Topic
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Forecasting
  • HIV / immunology
  • HIV Infections / immunology
  • HIV Infections / prevention & control
  • HIV-1 / immunology
  • HIV-2 / immunology
  • Haplorhini
  • Humans
  • Male
  • Neutralization Tests
  • Primates
  • Simian Immunodeficiency Virus / immunology

Substances

  • AIDS Vaccines
  • Antibodies, Viral